Showing results (71-80 of 123) with videos related to

Sort By:
Pageof 13
Rheumatology (Oxford, England)|December 26, 2016
Effect of tocilizumab on neutrophils in adult patients with rheumatoid arthritis: pooled analysis of data from phase 3 and 4 clinical trialsRobert J Moots, Anthony Sebba, William Rigby, et al.
Lancet (London, England)|June 18, 2018
Safety and efficacy of upadacitinib in patients with active rheumatoid arthritis refractory to biologic disease-modifying anti-rheumatic drugs (SELECT-BEYOND): a double-blind, randomised controlled phase 3 trialMark C Genovese, Roy Fleischmann, Bernard Combe, et al.
The Journal of Rheumatology|July 18, 2008
Effect of anakinra on functional status in patients with active rheumatoid arthritis receiving concomitant therapy with traditional disease modifying antirheumatic drugs: evidence from the OMEGA TrialXavier Le Loët, Dan Nordström, Manuel Rodriguez, et al.
BMJ Open|July 15, 2021
Cohort profile: SCREEN-RA: design, methods and perspectives of a Swiss cohort study of first-degree relatives of patients with rheumatoid arthritisBenoit Thomas P Gilbert, Céline Lamacchia, Denis Mongin, et al.
Rheumatology (Oxford, England)|May 17, 2022
Comparison of drug retention of TNF inhibitors, other biologics and JAK inhibitors in RA patients who discontinued JAK inhibitor therapyAndrea Amstad, Eleftherios Papagiannoulis, Almut Scherer, et al.
Medical Microbiology and Immunology|February 14, 2015
Increased frequency of JC-polyomavirus detection in rheumatoid arthritis patients treated with multiple biologicsJens Verheyen, Kseniya Maizus, Eugen Feist, et al.
Molecular Cancer Therapeutics|April 29, 2011
Induction of in vitro and in vivo NK cell cytotoxicity using high-avidity immunoligands targeting prostate-specific membrane antigen in prostate carcinomaRon D Jachimowicz, Giulio Fracasso, Paul J Yazaki, et al.
Arthritis Research & Therapy|March 28, 2014
Rituximab in patients with rheumatoid arthritis in routine practice (GERINIS): six-year results from a prospective, multicentre, non-interventional study in 2,484 patientsJoerg Wendler, Gerd R Burmester, Helmut Sörensen, et al.
Blood|April 19, 2012
Safety and efficacy of brentuximab vedotin for Hodgkin lymphoma recurring after allogeneic stem cell transplantationAjay K Gopal, Radhakrishnan Ramchandren, Owen A O'Connor, et al.
Annals of the Rheumatic Diseases|May 15, 2020
Canakinumab for Treatment of Adult-Onset Still's Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trialClaudia Kedor, Joachim Listing, Jan Zernicke, et al.
Pageof 13